Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sterigenics Reaches $408m Settlement In EtO Lawsuit

Executive Summary

Sterigenics concludes its ethylene oxide lawsuits with $408m settlement but does not admit liability.

You may also be interested in...



AdvaMed Urges Biden Administration Not To Shut Down EtO Sterilization Facilities

The trade group says that the Biden Administration should consider the lack of alternatives to ethylene oxide sterilization when considering new regulations on EtO.

Sterigenics Wins Second Lawsuit In Ongoing Ethylene Oxide Court Battles

In the second trial over Sterigenics’ ethylene oxide plant emissions, the Cook County, IL jury found Stergiencs not liable for cancer in a woman who lived near the plant.

Sterigenics Facing 700 Ethylene Oxide Suits In Chicago-Area Courts

The company plans to defend itself against the suits, which were brought by people who say EtO emissions caused cancers, miscarriages and other health problems.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147521

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel